In-Depth Research On:
Epizyme, Inc. (EPZM)

Sign Up Now to Download a Free Research Report on EPZM

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Epizyme, Inc.

Epizyme shares soared 75.56 percent to close at $35.99 a share Tuesday. The stock traded between $31.02 and $37.69 on volume 3.81 million shares traded. The company has announced that it has achieved a proof of concept milestone and has earned a $25.0 million payment from Celgene. Shares of Epizyme have gained approximately 55.0 percent in the past year.

Going forward ... (see research report)


RESEARCH REPORT ON EPZM
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on